Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Billionaire Chase Colemans Tiger Global Heavily Invested in Seven AI Stocks Zscalers AI Security Emphasis Raises Valuation Questions Amid Growth Demands Chinas Crypto Crackdown Faces Persistent CatandMouse Game Singapore Shares Edge Higher as Caution Persists Over Middle East Tensions STI Rises 04 American Graphics Signs Expands Fleet Graphics Installation Network to All 50 States Fox Corporation FOXA Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Edges Lower Corbus Pharmaceuticals Q1 2026 Earnings SmallerThanExpected Loss Amid Pipeline Progress IRIX Q1 2026 Earnings NarrowerThanExpected Loss Marks Positive Surprise Stock Yards Bancorp SYBT Q1 2026 Earnings Earnings Beat Estimates Amid Solid Performance EVER Q1 2026 Earnings Robust EPS Beat Fueled by Operational Discipline Gabelli Healthcare Wellness Trust GRX Holds Steady Near Support Navigating a Tight Trading Range Hologic Inc Holds Steady at 7601 as Traders Assess Support and Resistance Levels Central Puerto CEPU Springs Over 6 as Bullish Momentum Builds MINISO MNSO Slides 378 as Bears Test Key Support Near 1185 Estate Planning Essentials Navigating Inheritance Taxes and Family Financial Transitions Investors Turn to HALO Stocks as a Strategy to Own What AI Cannot Replace AutoNation Inc Faces Mixed Outlook Amid Evolving Auto Retail Landscape The Pitfalls of Chasing Returns Why a Disciplined Investment Approach Matters CDE Q1 2026 Earnings EPS Misses Estimates but Stock Rises 23 Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Brighthouse Financial BHFAM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Shares Edge Higher RM Q1 2026 Earnings EPS Surges Past Estimates as Regional Management Posts Strong Profit Beat PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances